Scholars Central

Conference abstractPublished 15 Sep 2016

MicroRNA-122 and lactate dehydrogenase (LDH) as response and prognostic markers in hepatocellular carcinoma (HCC)

Authors: A Makol, R Dhiman, Y Chawla, N Kalra, D Banerjee, A Chakraborti

Postgraduate Institute of Medical Education & Research, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Serum biomarkers are the non invasive tools to screen cancer in terms of detection, progression, and therapeutic response. These biomarkers may include biomolecules such as microRNAs and enzymes including lactate dehydrogenase (LDH). Their role as a probable diagnostic biomarker has been well defined in several cancers including hepatocellular carcinoma (HCC). HCC is the primary malignancy of the liver which may result in the deregulation of microRNAs (miRNAs). MicroRNA- 122(miR-122) is the predominant liver specific miRNA which is known to be down-regulated in HCC. Thus, we have looked into its potential as a prognostic and response biomarker against sorafenib. We observed a significant elevation (p<0.05) of miR-122 in the serum of HCC patients (n=70) as compared to healthy control (n=15) which is in agreement with the literature. Moreover, the expression of miR-122 was found to be significantly up-regulated (p<0.05) in metastatic serum samples vs. non metastatic. Furthermore, the serum level of miR-122 was evaluated to be significantly enhanced in sorafenib resistant patients (p<0.05) as compared to sensitive ones. Similarly, the serum LDH also showed an increased level in resistant patients which was further confirmed in vitro. Additionally, ROC curve analysis of miR-122 and LDH unveiled a high sensitivity and specificity of the assay. Further, miR-122 showed a positive correlation with LDH in serum. Hence, this study has highlighted the biomarker potential of miR-122 and LDH to investigate the prognosis of HCC and response towards sorafenib.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Molecular Biomarkers & Diagnosis
  • SubjectGenetics & Molecular Biology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “A Makol”
  • BylineArticles whose byline prints “R Dhiman”
  • BylineArticles whose byline prints “Y Chawla”
  • BylineArticles whose byline prints “N Kalra”
  • BylineArticles whose byline prints “D Banerjee”
  • BylineArticles whose byline prints “A Chakraborti”